The FDA approved the implant for humanitarian use Feb. 17 as the first 3D-printed patient specific talus spacer to treat avascular necrosis. The device includes a preoperative surgical planning application, which is a fully integrated cloud-based communication tool for surgeons and engineers to design the patient-specific implants.
Albert DaCosta, co-founder and CEO of Paragon 28, said the acquisition will accelerate the company’s move to leverage smart tools, artificial intelligence and advanced technology in patient care. Paragon is focused on the foot-and-ankle market and already offers the Apex 3D total ankle replacement system.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
